These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6279886)

  • 1. Improved cadaver allograft survival in transfused recipients who remain serologically negative for cytomegalovirus.
    Flechner SM; Novick AC; Steinmuller D
    J Urol; 1982 Apr; 127(4):644-7. PubMed ID: 6279886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal transplantation for end-stage polycystic kidney disease.
    Ho-Hsieh H; Novick AC; Steinmuller D; Streem SB; Buszta C; Goormastic M
    Urology; 1987 Oct; 30(4):322-6. PubMed ID: 3310365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transfusion effect.
    Iwaki Y; Cecka JM; Terasaki PI
    Clin Transpl; 1988; ():283-92. PubMed ID: 3154480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transfusion effect.
    Cecka JM
    Clin Transpl; 1987; ():287-301. PubMed ID: 3154420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of allograft survival in 100 consecutive cadaver kidney transplants.
    Flechner SM; Novick AC; Steinmuller D; Braun W; Buzsta C
    J Urol; 1982 Jun; 127(6):1084-6. PubMed ID: 7045404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UNOS Registry data: effect of transfusions.
    Cicciarelli J
    Clin Transpl; 1990; ():407-16. PubMed ID: 2103162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of blood transfusions on survival of cadaver and living related renal transplants.
    Oei LS; Thompson JS; Corry RJ
    Transplantation; 1979 Dec; 28(6):482-4. PubMed ID: 390787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection blocks the beneficial effect of pretransplant blood transfusion on renal allograft survival.
    Andrus CH; Betts RF; May AG; Freeman RB
    Transplantation; 1979 Dec; 28(6):451-6. PubMed ID: 229593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization and crossmatching in renal transplantation.
    Koka P; Cecka JM
    Clin Transpl; 1989; ():379-90. PubMed ID: 2487606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization in renal transplantation.
    Zhou YC; Cecka JM
    Clin Transpl; 1991; ():313-23. PubMed ID: 1820127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of high kidney graft survival rate by multiple transfusion.
    Opelz G; Graver B; Terasaki PI
    Lancet; 1981 Jun; 1(8232):1223-5. PubMed ID: 6112563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation.
    Cecka JM; Cicciarelli J; Mickey MR; Terasaki PI
    Transplantation; 1988 Jan; 45(1):81-6. PubMed ID: 3276068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of kidney-graft survival with increased numbers of blood transfusions.
    Opelz G; Terasaki PI
    N Engl J Med; 1978 Oct; 299(15):799-803. PubMed ID: 357971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant effect of transfusions on kidney graft survival.
    Opelz G; Terasaki PI
    Transplantation; 1980 Feb; 29(2):153-8. PubMed ID: 6986688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic factors determining survival of cadaver-kidney transplants. The effect of HLA serotyping, cytotoxic antibodies and blood transfusions on graft survival.
    Vincenti F; Duca RM; Amend W; Perkins HA; Cochrum KC; Feduska NJ; Salvatierra O
    N Engl J Med; 1978 Oct; 299(15):793-8. PubMed ID: 151230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial.
    Plotkin SA; Starr SE; Friedman HM; Brayman K; Harris S; Jackson S; Tustin NB; Grossman R; Dafoe D; Barker C
    Ann Intern Med; 1991 Apr; 114(7):525-31. PubMed ID: 1848053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infection and graft survival in renal graft recipients.
    Cappel R; Hestermans O; Toussaint C; Vereerstraeten P; van Beers D; de Braekeleer J; Schoutens E
    Arch Virol; 1978; 56(1-2):149-56. PubMed ID: 204269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney graft survival: role of blood transfusions and lymphocytotoxic antibodies.
    Fradet Y; Roy R; Lachance JG; Noël R
    Clin Nephrol; 1982 Aug; 18(2):69-73. PubMed ID: 6754190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience of blood transfusion in renal transplantation.
    Frisk B; Berglin E; Blohmé I; Persson H; Sandberg L; Wedel N; Brynger H
    Scand J Urol Nephrol Suppl; 1984; 88():1-69. PubMed ID: 6399773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.